Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Horizon Therapeutics Public (HZNP) News Today

Horizon Therapeutics Public logo
Horizon Therapeutics Public Lim (HZNP)
5 Biotech Acquisition Targets To Accumulate In 2024
Horizon Therapeutics Public Limited stock logo
Congress Asset Management Co. MA Decreases Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Congress Asset Management Co. MA lessened its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 80.4% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,645 shares of the
Horizon Therapeutics Public Limited stock logo
Tokio Marine Asset Management Co. Ltd. Has $10.94 Million Stock Holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Tokio Marine Asset Management Co. Ltd. cut its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 41.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 106,400 shares of the biopharmaceutic
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Purchased by National Bank of Canada FI
National Bank of Canada FI lifted its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 1,042.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 219,042 shares of the biopharmac
Horizon Therapeutics Public Limited stock logo
State of Alaska Department of Revenue Sells 23,645 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)
State of Alaska Department of Revenue lowered its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 36.3% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 41,511 shares of the biopharmaceutical co
Horizon Therapeutics Public Limited stock logo
DekaBank Deutsche Girozentrale Purchases 11,882 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)
DekaBank Deutsche Girozentrale increased its position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 8.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 150,
Horizon Therapeutics Public Limited stock logo
Olympiad Research LP Has $1.84 Million Position in Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Olympiad Research LP raised its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 30.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 17,857 shares of the biopharmaceutical
Rule 17(e) Announcement - Horizon Therapeutics plc
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public (NASDAQ:HZNP) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Horizon Therapeutics Public in a research report on Thursday. They set a "strong-buy" rating on the stock.
Rule 17(d) Announcement - Horizon Therapeutics plc
Rule 17(d) Announcement – Horizon Therapeutics plc
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Sold by SG Americas Securities LLC
SG Americas Securities LLC cut its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 96.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,318 shares of the b
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public Limited (NASDAQ:HZNP) Shares Sold by Congress Wealth Management LLC DE
Congress Wealth Management LLC DE reduced its stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 84.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,136 shares of t
Horizon Therapeutics Public Limited stock logo
Palliser Capital UK Ltd Has $8.17 Million Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Palliser Capital UK Ltd lessened its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 4.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 79,460 shares of the biopharma
Horizon Therapeutics Public Limited stock logo
Atria Wealth Solutions Inc. Sells 2,756 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Atria Wealth Solutions Inc. trimmed its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 31.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,998 shares of
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public Limited (NASDAQ:HZNP) is Syquant Capital Sas' Largest Position
Syquant Capital Sas grew its holdings in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 214.1% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 853,166 shares of the biopharmaceutical comp
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public (NASDAQ:HZNP) Upgraded by StockNews.com to Strong-Buy
StockNews.com raised Horizon Therapeutics Public from a "buy" rating to a "strong-buy" rating in a research note on Wednesday.
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public Limited (NASDAQ:HZNP) is Governors Lane LP's 2nd Largest Position
Governors Lane LP grew its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 193.8% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 451,800 shares of the biopharmaceutical company's stock after purchasing an additional
Horizon Therapeutics Public Limited stock logo
Renaissance Technologies LLC Purchases 1,693,400 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Renaissance Technologies LLC raised its position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 101.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,368,449 shares of the biopharmaceut
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public Limited (NASDAQ:HZNP) is Prosight Management LP's 9th Largest Position
Prosight Management LP lowered its position in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 10.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 81,035 shares of
growth stocks in September
3 Growth Stocks to Buy in September (HZNP)
As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings
Horizon Therapeutics Public Limited stock logo
Oxford Financial Group Ltd. Invests $273,000 in Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Oxford Financial Group Ltd. bought a new stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,500 shares of the biopharmaceutical
Horizon Therapeutics Public Limited stock logo
StockNews.com Lowers Horizon Therapeutics Public (NASDAQ:HZNP) to Buy
StockNews.com lowered Horizon Therapeutics Public from a "strong-buy" rating to a "buy" rating in a research report on Tuesday.
Horizon Therapeutics Public Limited stock logo
27,842 Shares in Horizon Therapeutics Public Limited (NASDAQ:HZNP) Purchased by FORA Capital LLC
FORA Capital LLC acquired a new position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 27,842 shares of the biopharmaceutical company's stock,
Horizon Therapeutics Public Limited stock logo
Allspring Global Investments Holdings LLC Decreases Stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Allspring Global Investments Holdings LLC cut its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 58.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 79,375 shares of the biopharmaceuti
Horizon Therapeutics Public Limited stock logo
Short Interest in Horizon Therapeutics Public Limited (NASDAQ:HZNP) Decreases By 7.7%
Horizon Therapeutics Public Limited (NASDAQ:HZNP - Get Free Report) was the target of a significant drop in short interest in August. As of August 15th, there was short interest totalling 7,860,000 shares, a drop of 7.7% from the July 31st total of 8,520,000 shares. Currently, 3.5% of the company's stock are short sold. Based on an average trading volume of 1,610,000 shares, the short-interest ratio is presently 4.9 days.
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public (NASDAQ:HZNP) Downgraded to Hold at Jefferies Financial Group
Jefferies Financial Group lowered Horizon Therapeutics Public from a "buy" rating to a "hold" rating in a research report on Friday.
Pharmacist checking stock values; Pharma stocks overview.
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks? (HZNP)
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
Horizon Therapeutics Public Limited stock logo
Horizon Therapeutics Public Limited (NASDAQ:HZNP) Given Consensus Recommendation of "Hold" by Brokerages
Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven analysts that are currently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation.
Horizon Therapeutics Public Limited stock logo
Ramius Advisors LLC Purchases Shares of 141,528 Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Ramius Advisors LLC acquired a new stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 141,528 shares of the biopharmaceutical company's stock, valued at app
Horizon Therapeutics Public Limited stock logo
Knott David M Jr Acquires 1,000 Shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Knott David M Jr lifted its holdings in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,490 shares of th
Horizon Therapeutics Public Limited stock logo
Credit Suisse AG Has $40.85 Million Position in Horizon Therapeutics Public Limited (NASDAQ:HZNP)
Credit Suisse AG boosted its stake in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP - Free Report) by 3.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 374,293 shares of the biopharmaceutical company's stock
Get Horizon Therapeutics Public News Delivered to You Automatically

Sign up to receive the latest news and ratings for HZNP and its competitors with MarketBeat's FREE daily newsletter.

24/7 Automated Profits in Crypto (Ad)

What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast world of passive crypto income, where you set up a dependable income stream that works for you, whether you're at your computer or living your life.

>> Secure Your Spot On The Groundbreaking Workshop Here

HZNP Media Mentions By Week

HZNP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HZNP
News Sentiment

0.00

0.68

Average
Medical
News Sentiment

HZNP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HZNP Articles
This Week

0

0

HZNP Articles
Average Week

Get Horizon Therapeutics Public News Delivered to You Automatically

Sign up to receive the latest news and ratings for HZNP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:HZNP) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners